Title
Valuing Companies in Emerging Markets: The Case of Nigeria,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Emerging markets offer a wealth of opportunities to investors. However, very little is known about how real managers and analysts appraise the economic value of acquisitions and investment projects in an emerging market such as Nigeria. Given the high risks of emerging markets and increased interests of investors in such markets, it is of great importance to research how practitioners carry out valuation in emerging markets. This book reviews different methods of valuation and the adjustments used for emerging markets. It investigates the valuation methods employed by managers of finance, investors and financial advisors in Nigeria in comparison with best practices recommended in literature. Quantitative analyses of survey data in the book show the percentage of practitioners using a particular method of valuation and the areas of highest uncertainty. Country specific issues such as computing country and market specific risk premiums are revealed. These analyses should be particularly useful to financial and business analysts, valuation practitioners, students of finance, companies and intending investors in emerging markets.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.